NGVT - CIK 0001653477
The table below shows Ingevity Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $331.20M | $128.60M | $205.10M | $313.40M | $293.30M | $352.40M |
| Capital expenditure | - | - | - | - | - | $82.10M |
| Investing cash flow | -$57.50M | -$79.50M | -$77.30M | -$551.90M | -$138.60M | -$110.60M |
| Dividends paid | - | - | - | - | - | - |
Ingevity Corp reported operating cash flow of $331.20M for fiscal year 2025. That is up 157.5% from $128.60M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $127.90M (FY 2016) to $331.20M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $56.30M | $0.00 | $92.10M | $145.20M | $109.40M | $88.00M |
| Financing cash flow | -$252.20M | -$70.20M | -$99.90M | $48.10M | -$133.10M | -$50.20M |